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Methods: A	 national	 population-	based	 case–	control	 study	 was	 conducted	 in	






Results: In	 all,	 82	 women	 were	 identified	 with	 DKA	 in	 pregnancy;	 6.3	 per	
100,000 maternities	(95%	CI:	5.0–	7.9).	No	maternal	deaths	occurred,	but	perina-
tal	mortality	was	12/73	(16%)	with	11 stillbirths	and	one	neonatal	death.	DKA	
episodes	 mostly	 occurred	 in	 women	 with	 type	 1	 diabetes	 (85%)	 and	 in	 the	 3rd	







Conclusion: DKA	 in	 pregnancy	 was	 associated	 with	 high	 perinatal	 mortality	
and	was	linked	with	factors	related	to	socio-	economic	deprivation,	mental	health	
problems	and	long-	term	difficulties	with	glycaemic	control.
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1 	 | 	 INTRODUCTION
Diabetic	ketoacidosis	(DKA)	is	characterised	by	hypergly-
caemia,	hyperketonaemia	and	metabolic	acidosis.	It	is	the	























pregnant	 women.18	 Regarding	 outcomes,	 DKA	 carries	
risks	for	both	the	pregnant	woman	and	the	fetus.10,11	Fetal	
and	 neonatal	 morbidity	 can	 be	 the	 direct	 consequence	
of	 the	 extremely	 poor	 tolerance	 of	 the	 fetus	 to	 acidosis,	











2 	 | 	 METHODS
2.1	 |	 Design
A	 population-	based	 matched	 case–	control	 study	 was	
designed	 using	 the	 UK	 Obstetric	 Surveillance	 System	
(UKOSS),	 a	 research	 platform	 that	 collects	 national	



















Controls	 were	 identified	 from	 the	 pregnant	 population	
with	 diabetes	 giving	 birth	 in	 all	 hospitals	 in	 the	 UK.	




What is already known?
•	 DKA	 in	 pregnancy	 is	 rare	 and	 carries	 a	 risk	
of	 morbidity	 and	 mortality	 for	 the	 pregnant	
woman	and	the	fetus




•	 No	 maternal	 deaths	 occurred,	 but	 perinatal	
mortality	and	rates	of	preterm	births	were	high
•	 15%	 of	 women	 with	 DKA	 episodes	 had	 more	
than	one	episode	in	their	pregnancy
What are the implications of the study?
•	 Particular	 attention	 should	 be	 paid	 to	 women	
at	high	risk	of	DKA;	guidelines	are	needed	on	
appropriate	 management	 following	 episodes	
of	DKA,	given	the	high	risk	of	recurrent	DKA,	
preterm	birth	and	later	stillbirth.










2.4	 |	 Data collection and consent
Information	about	each	patient	was	collected	by	the	local	





outcomes	 were	 collected.	 Birth	 outcomes	 included	 the	
mode	of	birth	and	the	indication	for	a	caesarean	section,	
if	applicable.	Indications	for	caesarean	sections	were	clas-






formed	 for	 any	 other	 indication.	 Neonates	 were	 defined	
as	 Small	 or	 Large	 for	 Gestational	 Age	 when	 their	 birth-
weight	was	below	the	10th	or	above	the	90th	centile	accord-





collection	 forms	and	 securely	 transferred	 from	hospitals	
to	 the	central	UKOSS	database	hosted	on	secure	servers	
at	 the	 University	 of	 Oxford.	 Individual	 consent	 was	 not	
required	for	collection	of	anonymous	data.









lower	 at	 0.41%.20	 Using	 this	 figure,	 the	 number	 of	 cases	










fidence	 interval	 (CI)	 were	 estimated.	 Denominator	 data	
were	 obtained	 from	 routine	 statistics	 published	 by	 the	
Office	 for	 National	 Statistics	 (For	 England	 and	 Wales),	




plied	 to	 the	 non-	pregnant	 population:	 women	 with	 an	
arterial	pH	<7.30	and/or	a	bicarbonate	level	<15 mmol/l	
and	 capillary	 ketonaemia	 of	 >3  mmol/l	 or	 ketonuria	 of	
>2	 pluses	 on	 dipstick	 testing.	 The	 incidence	 of	 ‘eugly-






paring	 demographic	 characteristics,	 delivery,	 maternal	





with	 DKA	 in	 women	 with	 type	 1	 diabetes.	 We	 adopted	
the	perspective	of	a	physician	aiming	to	identify	pregnant	




3 	 | 	 RESULTS
Between	February	2019	and	November	2020	(22 months	
recruiting	 period),	 83	 women	 were	 notified	 with	 DKA	
in	pregnancy	 in	 the	UK,	one	of	which	was	a	duplicate	
report.	 Cases	 were	 reported	 from	 65	 units	 (49	 units	
reporting	 one	 case,	 15	 units	 reporting	 two	 cases,	 one	
unit	 reporting	 3	 cases	 and	 129	 units	 confirming	 zero	
cases).	Cases	were	predominantly	 in	women	with	 type	










When	 considering	 only	 women	 with	 type	 1	 and	 type	
2	 diabetes,	 the	 incidences	 of	 DKA	 are	 estimated	 to	 be	







Three	of	 the	 later	stillbirths	occurred	at	35-	 to	37-	weeks	
gestation	 in	women	who	had	their	DKA	in	 their	2nd	 tri-


































fection	 (17/82;	 21%)	 and	 vomiting	 (17/82;	 21%).	 Steroid	
therapy	 in	 the	 context	 of	 possible	 preterm	 birth	 (11/82;	
13%)	 and	 medication	 errors	 (8/82;	 10%)	 were	 also	 fre-








Regarding	 neonatal	 outcome,	 63%	 of	 neonates	 (38/60)	
were	large	for	gestational	age	(LGA)	and	60%	(37/62)	were	
admitted	to	intensive	care.
3.3	 |	 Case– Control analysis
Out	of	the	population	of	women	with	DKA	(N = 82)	three-	




in	 these	 groups.	 Therefore,	 the	 case–	control	 analysis	
was	confined	to	women	with	type	1	diabetes.	Data	from	





ployment	 at	 the	 time	 of	 their	 first	 antenatal	 visit	 (26/70	
cases	(37%)	versus	8/69	controls	(12%);	OR	4.51	(95%	CI:	
1.86–	10.89))	and	were	more	likely	to	have	a	mental	health	
condition	 (12/70	 cases	 [17%]	 versus	 3/69	 controls	 [5%];	
OR	4.55	[95%	CI:	1.22–	16.9]).	Having	at	least	one	micro-





cases	 [32%]	versus	4/44	controls	 [9%];	OR	5.75	 [95%	CI:	
1.52–	21.73])	and	were	at	greater	 risk	of	 receiving	a	gen-
eral	 anaesthetic	 (13/40	 cases	 [32%]	 versus	 4/48	 controls	
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Gestational	age	at	diagnosis	of	DKA	(weeks) n = 66 n = 5 n = 7
First	trimester	(<13) 8	(12) 0 0
Second	trimester	(13–	27) 13	(20) 1	(20) 1	(14)
Third	trimester	(28	and	beyond) 45	(68) 4	(80) 6	(86)
Suspected	aetiology	of	the	DKA n = 70 n = 5 n = 7
Infection 15	(21) 1	(20) 1	(14)
Medication	error 6	(9) 2	(40) 0
Steroid	administration 8	(11) 0 3	(43)
Other	medication	or	mechanism 6	(9) 0 0
First	diagnosis	of	diabetes 3	(4) 0 0
Vomiting/hyperemesis 16	(23) 0 1	(14)




Median	[Q25,Q75] 14	[11,19] 10	[7,18] 7	[6,11]
<10 mmol/L 14	(22) 2	(40) 5	(71)
10–	<14 mmol/L 15	(23) 1	(20) 2	(29)
14–	<20 mmol/L 20	(31) 1	(20) 0
≥20 mmol/L 15	(23) 1	(20) 0
Base	excess/HCO3−	(mmol/L) n = 48 n = 5 n = 6
Median	[Q25,Q75] 11	[6,16] 18	[13,21] 16	[13,17]
<15 34	(71) 2	(40) 2	(33)
Blood	ketones	(mmol/L) n = 55 n = 5 n = 5
Median	[Q25,Q75] 4.0	[2.4,5.1] 5.1	[3.8,	6.4] 3.8	[1.4,	4.3]
≥3 36	(65) 5	(100) 3	(60)
pH/H+ n = 48 n = 5 n = 5
Median	[Q25,Q75] 7.31	[7.23,	7.37] 7.22	[7.14,	7.33] 7.33	[7.30,	7.37]
≤7.10 7	(15) 0 0
Sodium	(mmol/L) n = 67 n = 5 n = 7
<134 36	(54) 3	(60) 2	(29)
Potassium	(mmol/L) n = 65 n = 5 n = 7
<3.5 4	(6) 0 0
>4.5 27	(42) 1	(20) 0
MANAGEMENT
Highest	level	of	care n = 69 n = 5 n = 7
Medical/obstetric	ward 38	(55) 0 1	(14)
High	dependency	unit 15	(22) 2	(40) 5	(71)
Intensive	care	unit 16	(23) 3	(60) 1	(14)
Maternal	outcomes
Hypoglycaemia n = 54 n = 4 n = 6
6	(11) 0 1	(17)
Further	episodes	of	DKA n = 66 n = 5 n = 6
10	(15) 1	(20) 1	(14)











4 	 | 	 DISCUSSION









ulation	 in	 2018	 in	 the	 UK	 of	 3.51	 per	 1000	 births21	 and	
the	 overall	 stillbirth	 rate	 from	 2014	 to	 2018	 in	 pregnant	
women	 with	 type	 1	 or	 type	 2	 diabetes	 of	 13.7	 per	 1000	
births.20	 DKA	 episodes	 mostly	 occurred	 in	 women	 with	
type	 1	 diabetes	 and	 in	 the	 3rd	 trimester	 of	 pregnancy.	
Episodes	were	mainly	precipitated	by	infection,	vomiting,	




population-	based	 design	 enabling	 confirmation	 of	 the	
findings	from	previous,	albeit	underpowered,	studies	that	
perinatal	mortality	among	pregnant	women	with	DKA	is	







Whether	 it	 is	 maternal	 acidosis,	 maternal	 dehydration	
possibly	 leading	 to	 reduced	 uteroplacental	 perfusion,	 or	






other	 mechanism.	 Although	 first	 trimester	 glucose	 and/
or	HbA1c	data	were	not	available	in	this	study,	the	high	




tality	 is	due	 to	both	DKA	and	a	need	 for	better	diabetes	
management,	but	other	intercurrent	causes	of	fetal	death	
cannot	be	formally	ruled	out	from	these	data.	The	size	of	
this	 national	 population-	based	 study	 was	 limited	 by	 the	
low	incidence	of	the	condition,	but	we	believe	it	to	be	the	
largest	 contemporary	 cohort	 of	 pregnant	 women	 with	
DKA	described.	The	proportion	of	missing	data	is	below	
10%	 for	 most	 variables	 and	 missing	 data	 are	 largely	 ex-
plained	by	the	need	for	antenatal	transfers	in	cases	where	


















in	paid	work,	 suggesting	 that	 these	women	were	 from	a	
more	 socioeconomically	 deprived	 and	 vulnerable	 subset	
of	 the	 population	 with	 diabetes,	 which	 is	 a	 known	 risk	
factor	 for	DKA	in	the	general	population.25	The	associa-
tion	between	established	microvascular	complications	of	
diabetes	 and	 DKA	 in	 pregnancy	 suggests	 an	 association	
not	 only	 with	 difficulties	 with	 glucose	 management	 but	
also	 possibly	 long-	standing	 diabetes.	 More	 than	 10%	 of	
the	 women	 with	 DKA	 experienced	 at	 least	 one	 further	
episode	 during	 pregnancy,	 highlighting	 the	 need	 for	 en-
hanced	 diabetes	 and	 obstetric	 specialist	 support	 for	 this	
vulnerable	group.
Episodes	 of	 DKA	 occurred	 mainly	 in	 the	 third	 tri-
mester	and	the	reported	precipitants	included	infection,	
vomiting,	 steroids	 and	 medication	 error,	 which	 is	 con-
sistent	with	previous	studies.1,23	The	occurrence	of	DKA	
in	 later	 pregnancy	 is	 likely	 a	 manifestation	 of	 increas-




cies,	 but	 women	 with	 type	 1	 diabetes	 are	 at	 increased	
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T A B L E  2 	 Case–	control	comparison	of	maternal	characteristics,	delivery	characteristics	and	neonatal	outcomes	in	women	with	type	1	
diabetes
Women with type 1 diabetes and DKA (cases)
N = 70
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risk	of	infection28	and	so	special	emphasis	on	‘sick	day	
guidance’	 is	 required,	 including	 blood	 ketone	 testing.	
Pregnant	women	with	diabetes	are	at	 increased	risk	of	
delivering	 preterm20	 and	 antenatal	 steroids	 are	 known	
to	 benefit	 the	 baby	 if	 delivered	 prematurely.	 The	 high	
proportion	 of	 iatrogenic	 cases	 of	 DKA	 caused	 by	 pre-	




is	 a	 clear	 case	 for	 national	 and	 international	 guidance	
on	pre-	birth	steroids	in	women	with	diabetes.	Finally,	a	
high	number	of	DKA	cases	were	attributed	by	clinicians	
to	 hyperemesis	 or	 vomiting.	 This	 may	 have	 promoted	
DKA	 by	 prompting	 inappropriate	 insulin	 omission/re-
duction	and	by	causing	dehydration,	but	alternatively	it	




Women with type 1 diabetes and DKA (cases)
N = 70







































T A B L E  2 	 (Continued)








in	 pregnancy,	 increased	 expression	 of	 placental	 glucose	
transporters	 and	 increased	 glomerular	 filtration	 of	 glu-
cose	in	pregnancy.30
Importantly,	half	of	the	women	with	DKA	were	man-






5 	 | 	 CONCLUSION
DKA	 in	 pregnancy	 was	 associated	 with	 high	 perinatal	
mortality	 and	 was	 linked	 with	 factors	 related	 to	 socio-	
economic	 deprivation,	 mental	 illness	 and	 microvascular	
T A B L E  3 	 Association	between	pre-	pregnancy	and	pregnancy	
characteristics	and	DKA	in	women	with	type	1	diabetes











































































T A B L E  3 	 (Continued)
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